Division of Physiology and Pathology, National Institute of Radiological Sciences, 4-9-1 Anagawa, Inage-ku, Chiba-shi, Chiba 263, Japan Thomas [1] and Burnet [2] proposed that the immunosurveillance mechanism has an important role in suppressing tumor induction, with T-cells playing essential roles. According to this theory, it had been predicted that T-cell deficient animals would be susceptible to neoplastic diseases. However, earlier studies using athymic nude mice showed discrepant results depending on the experimental conditions. This immunosurveillance theory was generally supported in tumors induced by oncogenic viruses [3] [4] [5] [6] and spontaneous lymphoreticular neoplasms [7, 8] . However, this was not the case in chemical carcinogenesis ; many investigators reported that the latent period and tumor incidence in nude mice treated with urethan or methylcholanthrene were not significantly different from those in euthymic control mice [8- Animals : Male athymic nude mice (nu/ nu) and their female heterozygous littermates (nu/+) with a BALB/c background were supplied by the animal breeding facility of this institute, and then mated in our laboratory. Their offspring, nu/ nu and nu/+ mice, were housed in filter-topped metal cages, 6 or fewer per cage, and were maintained under specific pathogen-free conditions at 24t , 4560% humidity, and a 12-hour light-dark cycle. They were given a commercial pellet diet, MB -1 (Funabashi Farm Co ., Funabashi, Japan) and chlorinated (12 ppm) and acidified water (pH 3) ad libitum. Both male and female mice were used throughout the experiments, as sex difference does not influence lung tumorigenesis in these mice [3, [15] [16] [17] [18] .
Urethan : Urethan (ethyl carbamate) was obtained from Wako Pure Chemical Industries, Ltd. (Osaka, Japan). The 2.5% urethan solution dissolved in 0.9% NaCI solution (saline) and sterilized through a 0.22 ,um pore filter (Millipore Co., Mass., U. S. A .) . Approximately 5-me aliquots of the 2.5% urethan solution were distributed into glass tubes and stored at -20t until use. The frozen solution was thawed prior to administration and used within 1 hour. All frozen stocks of the solution were used within 3 months.
Administration Route : The urethan solution was intraperitoneally (i.p.) administered. To prevent the possibility of leakage of the solution, the injector needle was inserted via the leg muscles into the abdominal cavity [17].
Experimental Design : In experiment 1, the dose-tumor incidence relationship was examined. The flu/ flu and flu/ + mice were divided into 5 groups, ranging in number from 31 to 65 mice for each group. Mice of each group were treated with urethan or saline at 14 to 16 days of age : Group 1 (control), 0. In experiment 2, the development of lung tumor was sequentially examined. Both flu/flu and flu/ + mice were divided into two groups. Mice of the treated group were i . p , injected with a single dose of 0.5 mg/g b . w. of urethan at the age of 14 or 15 days. Age-matched mice given an i . p. injection of 0.15 ml of saline served as controls. Treated animals were sacrificed and autopsied 30 and 35 days, 2, 3, 4, 6, 8, 10 and 12 months after urethan-treatment. Control animals were sacrificed at 6 and 12 months after the start of the experiment. The lungs of all mice, and other gross lesions if present at autopsy, were fixed in 10% phosphate-buffered f ormalin . These sections were processed in a routine manner and stained with hematoxylin and eosin. A small number of mice died during the experiment and their carcasses were also examined as described above, but they were excluded from the present results.
Analysis
of Data : Statistical analysis of the experimental data was performed using Student's t-test or the x 2-test.
Results
Dose -Response in Incidence of Lung Tumors : Lung tumorigenesis in both nu/nu and nu/ + mice was closely linked to increases in the urethan dose (Fig. 1) . Lung tumor multiplicity was proportional to the square of the urethan dose, and fit well with linear-quadratic curves in both nu/ nu and nu/ + mice ; Y=2.56X2+1.38X+0.15 and Y=3.13X2+1.01 X + 0.20, respectively, where Y means the number of tumor nodules/mouse and X means the dose of urethan (mg/g b. w.). These two curves coincide except for the response at a dose of 1.5 mg/g b. w., but no significant difference was seen at this dose by t-test. This result may suggest that the frequency level of tumor initiation and of the ability to suppress tumor development did not differ between athymic and euthymic mice.
Sequential Observations of Lung Tumor Development : Time-dependent changes in the number of lung-tumor bearing mice and average multiplicity (number of tumor nodules/ mouse) of the lung tumors after urethan treatment are shown in Figs. 2 and 3 , respectively. No tumor nodule was observed at 28 days after urethan treatment. Tumors were first detected on the 35th day in both nu/ nu and nu/ + mice. The latent period in the present study was slightly longer than that reported by Shimkin and Polissar [191. There was no significant difference in incidence between these two phenotypically different mouse groups for a period of up to 12 months (Fig. 2) . The ratio of tumor bearing mice was 73% for nu/nu mice and 80% for nu/+ mice at the 6th month, and 96% for nu/ nu and 97% for nu/ + mice at the 12th month of the experiment. Tumor multiplicity in nu/nu mice was also comparable to that in nu/+ mice at all times of examination (Fig. 3) . It seemed to increase almost linearly with time in both nu/ nu and nu/ + mice. Neither the incidence nor the multiplicity of lung tumors in athymic nude mice differed from those of euthymic mice at any time up to the 12th month. These results show no shortening of the latent period in lung tumor development after urethan administration. No lung tumors were observed in control mice injected with saline at 6 months, while there were lung tumors in more than 70% of urethan-treated mice in the same period. The results of the present study demonstrate that lung tumorigenesis by urethan in BALB/c background nude mice, assessed by dose-response relationship, latent period, tumor incidence and multiplicity dose not differ from that of euthymic littermates. These results strongly suggest that the T-cell mediated immunosurveillance function is not operational in this model. In addition, it was assumed that NK cells and macrophages also do not exert any effect on carcinogenesis, because the activities of these cells are usually fairly high in nude mice in comparison with normal mice [20, 211, and there was no detectable decrease of tumor incidence or tumor multiplicities in our urethan-treated nude mice. It may be concluded that the immunosurveillance system mediated by not only T-cells but also NK cells and macrophages is not operating during urethan induction of lung tumors in mice. This coincides with the findings reported in the earlier literature on tumor development by urethan or methylcholanthrene in nude mice [8] [9] [10] [11] [12] .
On the other hand, oncogenic virus-induced carcinogenesis [3] [4] [5] [6] and oncogenesis by some carcinogenic chemicals, such as methylnitrosourea, ethylnitrosourea and dimethylbenzanthracene [13, 14] , support the concept of the immunosurveillance theory. In those studies, athymic nude mice developed more tumors than euthymic mice. From the results on experimental skin tumorigenesis by nitrosourea alone or combined with 12-otetradecanoyl-phorbol-l3-acetate (TPA) and by UV light, Anderson and Rice assumed that the skin anomalies in nude mice were a reflection of the higher susceptibility to tumorigenesis compared with normal mice [141. The development of spontaneous lymphoreticular neoplasms has also been reported to be predominant in athymic mice [7, 8] . It is still unclear why the immunosurveillance mechanism acts in virus-induced and spontaneous oncogenesis but not in urethan-induced tumorigenesis. More information is needed to elucidate the mechanism of tumor-development suppression. 
